Human immunoglobulin (intramuscular) (Sinopharm Shanghai Plasma-Derived Biotherapies)

人免疫球蛋白（上海血液制品）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman immunoglobulin (intramuscular) (Sinopharm Shanghai Plasma-Derived Biotherapies)
Drug Alias Namehuman immunoglobulin (intramuscular), Shanghai Institute of Biological Products
ClassificationBiologicsBiologics > Blood components
Mechanisms of ActionImmunoglobulin agonists
TargetsImmunoglobulin
Therapy Area/IndicationsHepatitisMeasles
Global Approved IndicationsHepatitisMeasles
Approved Indications in ChinaHepatitisMeasles
Original Approved Country/TerritoryMainland China
Original Approved Date1997/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSinopharm Shanghai Plasma-Derived Biotherapies Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Institute of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitisMeasles
Inactive IndicationsN/A

Other Information

ATC CodeJ06BA01
Related LinksN/A